Novavax | NVAX - Ebitda





Ebitda Cambio Fecha
Adma Biologics USD 73.59M 14.85M 2025-12
Agenus USD -10.11M 19.02M 2025-03
AstraZeneca USD 5.67B 1.29B 2026-03
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Cassava Sciences USD -11.73M 33.44M 2025-09
Geron USD -21.29M 11.82M 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
MannKind USD -3.05M 20.97M 2025-12
Merck USD 6.3B 2.09B 2025-12
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Moderna USD -790M 582M 2025-12
Novartis USD 5.84B 235M 2025-09
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 5.99B 5.23B 2026-03
Sanofi EUR 3.31B 3.65B 2026-03
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
TG Therapeutics USD 51.69M 19M 2025-12